Announcements
Trials
Browse
Landscape
Eligibility
Clinical Trials
5 trials
Recent
Start date
Enrollment
Phase 3
×
Carcinoma, Non-Small-Cell Lung
×
Cyclophosphamide
×
Clear all
Filters
3
NCT02187367
2019-09-10
EGF
Bioven Sdn. Bhd.
Phase 3
Terminated
106 enrolled
NCT02049151
2017-08-23
START2
EMD Serono
Phase 3
Terminated
35 enrolled
10 charts
NCT01015443
2016-10-26
INSPIRE
Merck KGaA, Darmstadt, Germany
Phase 3
Terminated
285 enrolled
12 charts
NCT00409188
2015-11-20
START
EMD Serono
Phase 3
Completed
1,513 enrolled
12 charts
NCT01444118
2015-07-22
NSCLC
Bioven Sdn. Bhd.
Phase 3
Terminated